BioXcel Therapeutics, Inc. (BTAI)
NASDAQ: BTAI · Real-Time Price · USD
1.850
0.00 (0.00%)
Apr 25, 2025, 4:00 PM EDT - Market closed
BioXcel Therapeutics Market Cap
BioXcel Therapeutics has a market cap or net worth of $10.12 million as of April 25, 2025. Its market cap has decreased by -87.13% in one year.
Market Cap
10.12M
Enterprise Value
83.21M
1-Year Change
-87.13%
Ranking
Category
Stock Price
$1.85
Market Cap Chart
Since March 8, 2018, BioXcel Therapeutics's market cap has decreased from $172.57M to $10.12M, a decrease of -94.14%. That is a compound annual growth rate of -32.81%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 784.84B |
| UnitedHealth Group | 379.95B |
| Johnson & Johnson | 369.48B |
| AbbVie | 329.07B |
| Novo Nordisk | 276.96B |
| Abbott Laboratories | 222.65B |
| AstraZeneca | 215.41B |
| Novartis AG | 211.71B |